Related Experiment Videos
Increased MMP-2 in healthy postmenopausal women
María Luz Muzzio1, Veronica Miksztowicz, Esteban Martín Repetto
1Laboratory of Lipids and Lipoproteins, Physiopathology and Clinical Biochemistry Institute, Faculty of Pharmacy and Biochemistry, University of Buenos Aires, Junin 956 (1113), Buenos Aires, Argentina.
Background:
Matrix metalloproteases 2 (MMP-2) and 9 (MMP-9) are involved in the atherosclerosis process. The objective of the study was to evaluate MMP-2 and MMP-9 activities and other circulating inflammatory factors in healthy postmenopausal women (PMW) as a model of subclinical atherosclerosis.
Methods:
Twenty-three PMW and 13 premenopausal women (PreMW) were selected following established criteria. The main measurements in plasma samples were: lipid-lipoprotein profile, high-sensitivity C-reactive protein (hs-CRP) (immunoturbidimetry), soluble vascular cellular adhesion molecules (sVCAM-1) enzyme-linked immunosorbent assay and MMP activity by zymography.
Results:
The relative areas of MMP-2 were increased in PMW: 1.1 (0.1) versus 0.6 (0.05), P < 0.02. MMP-9 was only detected in three PMW and one PreMW. MMP-2 correlated with HDL-cholesterol (r = -0.51), triglycerides (r = 0.67), apolipoprotein B (r = 0.47), hs-CRP (r = 0.42), homeostasis model assessment (r = 0.53) and waist circumference (r = 0.40), at least P < 0.02. sVCAM-1 showed no difference between groups: 28.7 (5.5) versus 35.5 (20) ng/mL, but correlated with MMP-2 and hs-CRP (r = 0.46 and r = 0.48 respectively, P < 0.05).
Conclusions:
In postmenopause, the increase in MMP-2 reflects the systemic specific inflammatory process that accompanies atherogenesis.
Insights
Postmenopausal women show increased matrix metalloproteinase-2 (MMP-2) activity, a marker of subclinical atherosclerosis. This elevation in MMP-2 activity is linked to inflammatory factors and metabolic changes, suggesting a role in the atherogenesis process.
Area of Science:
- Cardiovascular research
- Biomarkers of atherosclerosis
- Menopause-related health
Background:
- Matrix metalloproteinases 2 (MMP-2) and 9 (MMP-9) are implicated in atherosclerosis.
- Postmenopausal women (PMW) serve as a model for subclinical atherosclerosis.
Purpose of the Study:
- To evaluate MMP-2 and MMP-9 activities in healthy PMW.
- To assess other circulating inflammatory factors in PMW.
- To understand subclinical atherosclerosis markers in postmenopause.
Main Methods:
- Plasma samples from 23 PMW and 13 premenopausal women (PreMW) were analyzed.
- Measurements included lipid profile, high-sensitivity C-reactive protein (hs-CRP), soluble vascular cellular adhesion molecules (sVCAM-1), and MMP activity via zymography.
Main Results:
- MMP-2 activity was significantly higher in PMW compared to PreMW (P < 0.02).
- MMP-2 levels correlated with HDL-cholesterol, triglycerides, apolipoprotein B, hs-CRP, HOMA-IR, and waist circumference (P < 0.02).
- sVCAM-1 showed no group difference but correlated with MMP-2 and hs-CRP (P < 0.05).
Conclusions:
- Increased MMP-2 activity in postmenopause indicates a systemic inflammatory process.
- This process is associated with atherogenesis.
- MMP-2 may be a key biomarker in subclinical atherosclerosis development during postmenopause.
Related Concept Videos
Role of Matrix Metalloproteases in Degradation of ECM
A...
Menopause
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Abnormal Proliferation